{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:12:14Z","timestamp":1790759534667,"version":"4.1.0"},"reference-count":139,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02979","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T05:16:16Z","timestamp":1545196576000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.3389","volume":"9","author":[{"given":"Wei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1423493","DOI":"10.1155\/2016\/1423493","article-title":"Haploidentical hematopoietic stem cell transplantation: expanding the horizon for hematologic disorders","volume":"2016","author":"Zahid","year":"2016","journal-title":"Adv Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev.immunol.25.022106.141606","article-title":"Immunobiology of allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Welniak","year":"2007","journal-title":"Annu Rev Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2003-02-0342","article-title":"Graft-versus-leukemia reactions in allogeneic chimeras","volume":"103","author":"Kolb","year":"2004","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.med.54.101601.152339","article-title":"Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant","volume":"54","author":"Vogelsang","year":"2003","journal-title":"Annu Rev Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"608951","DOI":"10.1155\/2013\/608951","article-title":"Regulatory T cells in allogeneic stem cell transplantation","volume":"2013","author":"Michael","year":"2013","journal-title":"Clin Dev Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbmt.2014.10.029","article-title":"B cells in chronic graft-versus-host disease","volume":"21","author":"Sarantopoulos","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1182\/blood-2008-10-161638","article-title":"The role of B cells in the pathogenesis of graft-versus-host disease","volume":"114","author":"Shimabukuro-Vornhagen","year":"2009","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000445325","article-title":"Natural killer cells for therapy of leukemia","volume":"43","author":"Suck","year":"2016","journal-title":"Transfus Med Hemother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fimmu.2016.00144","article-title":"Functional reconstitution of natural killer cells in allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ullah","year":"2016","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood.V67.5.1302.1302","article-title":"Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation","volume":"67","author":"de Witte","year":"1986","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/10428190310001615684","article-title":"Allogeneic transplantation of CD34+ selected hematopoietic cells\u2013clinical problems and current challenges","volume":"45","author":"Platzbecker","year":"2004","journal-title":"Leuk lymphoma"},{"key":"B16","first-page":"3996","article-title":"T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.4049\/jimmunol.164.9.4564","article-title":"CD28-specific antibody prevents graft-versus-host disease in mice","volume":"164","author":"Yu","year":"2000","journal-title":"J Immunol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.4049\/jimmunol.157.8.3250","article-title":"Infusion of anti-B7","volume":"157","author":"Blazar","year":"1996","journal-title":"J Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1182\/blood-2009-04-218248","article-title":"Superagonistic CD28 stimulation of allogeneic T cells protects from acute graft-versus-host disease","volume":"114","author":"Beyersdorf","year":"2009","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1182\/blood-2013-05-500801","article-title":"Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality","volume":"122","author":"Saha","year":"2013","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.4049\/jimmunol.1400954","article-title":"Programmed death-1 pathway in host tissues ameliorates Th17\/Th1-mediated experimental chronic graft-versus-host disease","volume":"193","author":"Fujiwara","year":"2014","journal-title":"J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1172\/JCI12156","article-title":"LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation","volume":"107","author":"Cooke","year":"2001","journal-title":"J Clin Invest."},{"key":"B23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1182\/blood-2003-12-4241","article-title":"Tumor necrosis factor-alpha blockade for the treatment of acute GVHD","volume":"104","author":"Couriel","year":"2004","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1182\/blood-2002-03-0985","article-title":"Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation","volume":"100","author":"Antin","year":"2002","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/path.4475","article-title":"Glucocorticoids attenuate acute graft-versus-host disease by suppressing the cytotoxic capacity of CD8(+) T cells","volume":"235","author":"Theiss-Suennemann","year":"2015","journal-title":"J Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/blood-2014-02-514745","article-title":"The biology of graft-versus-host disease: experimental systems instructing clinical practice","volume":"124","author":"Markey","year":"2014","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nri1961","article-title":"Interferons, immunity, and cancer immunoediting","volume":"6","author":"Dunn","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1182\/blood-2002-07-2109","article-title":"Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation","volume":"101","author":"Schmaltz","year":"2003","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.immunol.20.100201.131730","article-title":"Lymphocyte-mediated cytotoxicity","volume":"20","author":"Russell","year":"2002","journal-title":"Annu Rev Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1182\/blood-2006-10-054510","article-title":"Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity","volume":"110","author":"Borsotti","year":"2007","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nri775","article-title":"Cytolytic pathways in haematopoietic stem-cell transplantation","volume":"2","author":"van den Brink","year":"2002","journal-title":"Nat Rev Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1182\/blood.V97.9.2886","article-title":"Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect","volume":"97","author":"Schmaltz","year":"2001","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1172\/JCI119606","article-title":"Perforin\/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation","volume":"100","author":"Graubert","year":"1997","journal-title":"J Clin Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.4049\/jimmunol.1201989","article-title":"Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms","volume":"190","author":"Yu","year":"2013","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.4049\/jimmunol.179.3.1669","article-title":"IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease","volume":"179","author":"Ramirez-Montagut","year":"2007","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1002\/ijc.21658","article-title":"TRAIL-induced cell death cooperates with IFN-gamma activation in the graft-versus-tumor effect against colon tumors","volume":"118","author":"Tateishi","year":"2006","journal-title":"Int J Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/nm1202-797","article-title":"T cells require TRAIL for optimal graft-versus-tumor activity","volume":"8","author":"Schmaltz","year":"2002","journal-title":"Nat Med."},{"key":"B38","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1182\/blood.V93.8.2738","article-title":"Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation","volume":"93","author":"Tsukada","year":"1999","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1182\/blood.V93.12.4071","article-title":"Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease","volume":"93","author":"Pan","year":"1999","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nri2570","article-title":"CD95, BIM and T cell homeostasis","volume":"9","author":"Bouillet","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/356314a0","article-title":"Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis","volume":"356","author":"Watanabe-Fukunaga","year":"1992","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","article-title":"Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand","volume":"76","author":"Takahashi","year":"1994","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1084\/jem.181.1.71","article-title":"Fas ligand mediates activation-induced cell death in human T lymphocytes","volume":"181","author":"Alderson","year":"1995","journal-title":"J Exp Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/intimm\/7.9.1451","article-title":"Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo","volume":"7","author":"Mogil","year":"1995","journal-title":"Int Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.4049\/jimmunol.167.5.2936","article-title":"Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease","volume":"167","author":"Wasem","year":"2001","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.4049\/jimmunol.161.6.2848","article-title":"Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production","volume":"161","author":"Shustov","year":"1998","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.leukres.2011.08.005","article-title":"Elevated Fas\/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis","volume":"36","author":"Wu","year":"2012","journal-title":"Leuk Res."},{"key":"B49","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.V91.4.1464","article-title":"Soluble Fas levels in sera of bone marrow transplantation recipients are increased during acute graft-versus-host disease but not during infections","volume":"91","author":"Liem","year":"1998","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.4049\/jimmunol.157.12.5387","article-title":"A major role for the Fas pathway in acute graft-versus-host disease","volume":"157","author":"Via","year":"1996","journal-title":"J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1084\/jem.183.2.657","article-title":"Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease","volume":"183","author":"Braun","year":"1996","journal-title":"J Exp Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1084\/jem.183.6.2645","article-title":"The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice","volume":"183","author":"Baker","year":"1996","journal-title":"J Exp Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/TP.0b013e3182708e7c","article-title":"Multiple single-nucleotide polymorphism-based risk model for clinical outcomes after allogeneic stem-cell transplantation, especially for acute graft-versus-host disease","volume":"94","author":"Kim","year":"2012","journal-title":"Transplantation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4049\/jimmunol.0800561","article-title":"Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand","volume":"183","author":"Bohana-Kashtan","year":"2009","journal-title":"J Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.exphem.2004.07.017","article-title":"Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioning","volume":"32","author":"Prigozhina","year":"2004","journal-title":"Exp Hematol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/01.tp.0000229435.58898.c5","article-title":"Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease","volume":"82","author":"Georgantas","year":"2006","journal-title":"Transplantation"},{"key":"B57","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/bmt.2014.12","article-title":"Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts","volume":"49","author":"Mizrahi","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.transproceed.2013.01.029","article-title":"Mouse T cells engineered to display on their surface a novel form of FasL protein undergo apoptosis when stimulated with alloantigens: implications for graft-versus-host disease","volume":"45","author":"Yolcu","year":"2013","journal-title":"Transplant Proc."},{"key":"B59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1182\/blood-2003-03-0909","article-title":"Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression","volume":"103","author":"Socie","year":"2004","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1182\/blood.V96.3.1047","article-title":"Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses","volume":"96","author":"Hsieh","year":"2000","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.trim.2012.07.001","article-title":"Failure of chimerism formation and tolerance induction from Fas ligand mutant bone marrow donors after nonmyeloablative conditioning","volume":"27","author":"Nusair","year":"2012","journal-title":"Transpl Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4049\/jimmunol.164.1.469","article-title":"Fas-deficient lpr mice are more susceptible to graft-versus-host disease","volume":"164","author":"van Den Brink","year":"2000","journal-title":"J Immunol."},{"key":"B63","first-page":"184","article-title":"Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease","volume":"70","author":"van den Brink","year":"2000","journal-title":"Transplantation"},{"key":"B64","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bbmt.2012.10.004","article-title":"Depletion of naive lymphocytes with fas ligand ex vivo prevents graft-versus-host disease without impairing T cell support of engraftment or graft-versus-tumor activity","volume":"19","author":"Askenasy","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B65","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.exphem.2013.04.016","article-title":"Immunomodulation with donor regulatory T cells armed with Fas-ligand alleviates graft-versus-host disease","volume":"41","author":"Yolcu","year":"2013","journal-title":"Exp Hematol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1126\/science.7518614","article-title":"Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity","volume":"265","author":"Kagi","year":"1994","journal-title":"Science"},{"key":"B67","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/00007890-199708270-00004","article-title":"CD4+ and CD8+ T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients","volume":"64","author":"Blazar","year":"1997","journal-title":"Transplantation"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1182\/blood-2004-08-3036","article-title":"Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease","volume":"105","author":"Maeda","year":"2005","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/01.TP.0000110416.96307.D5","article-title":"Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients","volume":"77","author":"Marks","year":"2004","journal-title":"Transplantation"},{"key":"B70","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.bbmt.2005.05.006","article-title":"Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways","volume":"11","author":"Zimmerman","year":"2005","journal-title":"Biol Blood Marrow Transplant."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/j.1600-6143.2007.01889.x","article-title":"Islet allograft rejection by contact-dependent CD8+ T cells: perforin and FasL play alternate but obligatory roles","volume":"7","author":"Sleater","year":"2007","journal-title":"Am J Transplant."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1172\/JCI1268","article-title":"Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation","volume":"101","author":"Asai","year":"1998","journal-title":"J Clin Invest."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1182\/blood-2009-05-222190","article-title":"NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects","volume":"115","author":"Olson","year":"2010","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/TP.0b013e318212c833","article-title":"The involvement of epithelial Fas in a human model of graft versus host disease","volume":"91","author":"Ruffin","year":"2011","journal-title":"Transplantation"},{"key":"B76","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/labinvest.3700541","article-title":"CD95 ligand-dependant endothelial cell death initiates oral mucosa damage in a murine model of acute graft versus host disease","volume":"87","author":"Deschaumes","year":"2007","journal-title":"Lab Invest."},{"key":"B77","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1172\/JCI39395","article-title":"The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease","volume":"120","author":"Na","year":"2010","journal-title":"J Clin Invest."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4049\/jimmunol.174.3.1291","article-title":"The role of p53 and Fas in a model of acute murine graft-versus-host disease","volume":"174","author":"Yada","year":"2005","journal-title":"J Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1182\/blood-2008-11-191148","article-title":"Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease","volume":"114","author":"Rotolo","year":"2009","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nm0497-409","article-title":"Essential roles of the Fas ligand in the development of hepatitis","volume":"3","author":"Kondo","year":"1997","journal-title":"Nat Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1172\/JCI896","article-title":"Fas ligand- mediated killing by intestinal intraepithelial lymphocytes","volume":"101","author":"Lin","year":"1998","journal-title":"J Clin Invest."},{"key":"B82","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1182\/blood.V91.11.4051","article-title":"Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies","volume":"91","author":"Hattori","year":"1998","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1136\/gut.45.2.229","article-title":"Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor alpha and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy","volume":"45","author":"Stuber","year":"1999","journal-title":"Gut"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1182\/blood-2015-06-652453","article-title":"IFN-gamma-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure","volume":"126","author":"Chen","year":"2015","journal-title":"Blood"},{"key":"B85","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood.V90.2.542","article-title":"A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice","volume":"90","author":"Hattori","year":"1997","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1083-8791(99)70012-1","article-title":"Graft-vs","volume":"5","author":"Ito","year":"1999","journal-title":"Biol Blood Marrow Transplant."},{"key":"B87","first-page":"554","article-title":"Electron microscopic demonstration of lesions in target cell membranes associated with antibody-dependent cellular cytotoxicity","volume":"42","author":"Dourmashkin","year":"1980","journal-title":"Clin Exp Immunol."},{"key":"B88","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.4049\/jimmunol.132.6.3197","article-title":"Purification and properties of cytoplasmic granules from cytotoxic rat LGL tumors","volume":"132","author":"Millard","year":"1984","journal-title":"J Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/0092-8674(87)90544-7","article-title":"A family of serine esterases in lytic granules of cytolytic T lymphocytes","volume":"49","author":"Masson","year":"1987","journal-title":"Cell"},{"key":"B90","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/cdd.2011.153","article-title":"A quarter century of granzymes","volume":"19","author":"Ewen","year":"2012","journal-title":"Cell Death Differ."},{"key":"B91","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev.immunol.26.021607.090404","article-title":"Death by a thousand cuts: granzyme pathways of programmed cell death","volume":"26","author":"Chowdhury","year":"2008","journal-title":"Ann Rev Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"491","DOI":"10.4049\/jimmunol.1401214","article-title":"Granzymes regulate proinflammatory cytokine responses","volume":"194","author":"Wensink","year":"2015","journal-title":"J Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1242\/jcs.03239","article-title":"Granzymes at a glance","volume":"119","author":"Bots","year":"2006","journal-title":"J Cell Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/cdd.2014.180","article-title":"Granzyme B-induced mitochondrial ROS are required for apoptosis","volume":"22","author":"Jacquemin","year":"2014","journal-title":"Cell Death Differ."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/labinvest.2009.91","article-title":"Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma","volume":"89","author":"Boivin","year":"2009","journal-title":"Lab Invest."},{"key":"B96","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood.V87.4.1232.bloodjournal8741232","article-title":"The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection","volume":"87","author":"Graubert","year":"1996","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.4049\/jimmunol.1200391","article-title":"Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis","volume":"190","author":"Capitini","year":"2013","journal-title":"J Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"eaam7828","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci Transl Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1182\/blood-2004-03-0859","article-title":"Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells","volume":"104","author":"Grossman","year":"2004","journal-title":"Blood"},{"key":"B100","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.immuni.2004.09.002","article-title":"Human T regulatory cells can use the perforin pathway to cause autologous target cell death","volume":"21","author":"Grossman","year":"2004","journal-title":"Immunity"},{"key":"B101","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1182\/blood-2009-12-257253","article-title":"In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia","volume":"116","author":"Choi","year":"2010","journal-title":"Blood"},{"key":"B102","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","article-title":"Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance","volume":"27","author":"Cao","year":"2007","journal-title":"Immunity"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1182\/blood-2009-07-233676","article-title":"Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease","volume":"115","author":"Cai","year":"2010","journal-title":"Blood"},{"key":"B104","first-page":"22","article-title":"Granzyme B contributes to the optimal graft-versus-tumor effect mediated by conventional CD4+ T Cells","volume":"1","author":"Du","year":"2016","journal-title":"J Immunol Res Ther."},{"key":"B105","doi-asserted-by":"publisher","first-page":"e0124927","DOI":"10.1371\/journal.pone.0124927","article-title":"Granzyme A is required for regulatory T-Cell mediated prevention of gastrointestinal graft-versus-host disease","volume":"10","author":"Velaga","year":"2015","journal-title":"PLoS ONE"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1182\/blood-2011-05-352708","article-title":"Human regulatory T cells in allogeneic stem cell transplantation","volume":"118","author":"Ukena","year":"2011","journal-title":"Blood"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4049\/jimmunol.1201554","article-title":"Granzyme B-mediated damage of CD8+ T cells impairs graft-versus-tumor effect","volume":"190","author":"Bian","year":"2013","journal-title":"J Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.4049\/jimmunol.1201206","article-title":"A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease","volume":"189","author":"Ding","year":"2012","journal-title":"J Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e1397247","DOI":"10.1080\/2162402X.2017.1397247","article-title":"Serine protease inhibitor 6 protects alloreactive T cells from Granzyme B-mediated mitochondrial damage without affecting graft-versus-tumor effect","volume":"7","author":"Du","year":"2018","journal-title":"Oncoimmunology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.bbmt.2018.07.003","article-title":"Host-derived serine protease inhibitor 6 provides granzyme B-independent protection of intestinal epithelial cells in murine graft-versus-host disease","volume":"24","author":"Mohammadpour","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"B111","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.4049\/jimmunol.1500668","article-title":"Granzyme B-mediated activation-induced death of CD4+ T cells inhibits murine acute graft-versus-host disease","volume":"195","author":"Du","year":"2015","journal-title":"J Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1182\/blood-2007-09-112987","article-title":"Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease","volume":"111","author":"Levine","year":"2008","journal-title":"Blood"},{"key":"B113","first-page":"635","article-title":"Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation","volume":"12","author":"Rowbottom","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","article-title":"The tumor necrosis factor ligand and receptor families","volume":"334","author":"Bazzoni","year":"1996","journal-title":"N Engl J Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri3834","article-title":"Regulation of tumour necrosis factor signalling: live or let die","volume":"15","author":"Brenner","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B116","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V75.4.1011.1011","article-title":"Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation","volume":"75","author":"Holler","year":"1990","journal-title":"Blood"},{"key":"B117","first-page":"243","article-title":"Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications","volume":"2","author":"Or","year":"1996","journal-title":"Cytokines Mol Ther."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1182\/blood-2008-02-138867","article-title":"Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival","volume":"112","author":"Choi","year":"2008","journal-title":"Blood"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.bbmt.2012.03.013","article-title":"TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes","volume":"18","author":"Choi","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"key":"B120","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1182\/blood-2009-03-212290","article-title":"Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the blood and marrow transplant clinical trials network","volume":"114","author":"Alousi","year":"2009","journal-title":"Blood"},{"key":"B121","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.bbmt.2008.04.006","article-title":"Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation","volume":"14","author":"Hamadani","year":"2008","journal-title":"Biol Blood Marrow Transplant."},{"key":"B122","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s12185-011-0803-1","article-title":"Implications of TNF-alpha in the pathogenesis and management of GVHD","volume":"93","author":"Levine","year":"2011","journal-title":"Int J Hematol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fimmu.2018.00356","article-title":"The effect of TNF-alpha on regulatory T cell function in graft-versus-host disease","volume":"9","author":"Mancusi","year":"2018","journal-title":"Front Immunol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1182\/blood-2016-02-700849","article-title":"Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells","volume":"128","author":"Leclerc","year":"2016","journal-title":"Blood"},{"key":"B125","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/imr.12151","article-title":"The complex and central role of interferon-gamma in graft-versus-host disease and graft-versus-tumor activity","volume":"258","author":"Wang","year":"2014","journal-title":"Immunol Rev."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1172\/JCI4992","article-title":"Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12","volume":"102","author":"Yang","year":"1998","journal-title":"J Clin Invest."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1172\/JCI3906","article-title":"Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice","volume":"102","author":"Murphy","year":"1998","journal-title":"J Clin Invest."},{"key":"B128","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1182\/blood-2008-07-168419","article-title":"Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury","volume":"113","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"B129","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1182\/blood-2002-04-1252","article-title":"Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation","volume":"100","author":"Reddy","year":"2002","journal-title":"Blood"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1084\/jem.194.10.1433","article-title":"Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis","volume":"194","author":"Reddy","year":"2001","journal-title":"J Exp Med."},{"key":"B131","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1182\/blood.V91.9.3315","article-title":"Interleukin-12 inhibits graft-versus-host disease through an Fas-mediated mechanism associated with alterations in donor T-cell activation and expansion","volume":"91","author":"Dey","year":"1998","journal-title":"Blood"},{"key":"B132","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ebiom.2018.01.002","article-title":"Enhanced immunosuppressive properties of human mesenchymal stem cells primed by interferon-gamma","volume":"28","author":"Kim","year":"2018","journal-title":"EBioMedicine"},{"key":"B133","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood.V90.11.4651","article-title":"Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice","volume":"90","author":"Yang","year":"1997","journal-title":"Blood"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.4049\/jimmunol.1200413","article-title":"IFN-gamma production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease","volume":"189","author":"Koenecke","year":"2012","journal-title":"J Immunol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.277.5327.818","article-title":"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors","volume":"277","author":"Sheridan","year":"1997","journal-title":"Science"},{"key":"B136","doi-asserted-by":"publisher","first-page":"29440","DOI":"10.18632\/oncotarget.4984","article-title":"TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells","volume":"6","author":"Lelaidier","year":"2015","journal-title":"Oncotarget"},{"key":"B137","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1172\/JCI66301","article-title":"Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity","volume":"123","author":"Ghosh","year":"2013","journal-title":"J Clin Invest."},{"key":"B138","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.trim.2007.05.012","article-title":"Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation","volume":"18","author":"Nomura","year":"2007","journal-title":"Transpl Immunol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nrclinonc.2014.102","article-title":"Current and emerging strategies for the prevention of graft-versus-host disease","volume":"11","author":"Choi","year":"2014","journal-title":"Nat Rev Clin Oncol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02979\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T08:20:55Z","timestamp":1694506855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02979\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":139,"alternative-id":["10.3389\/fimmu.2018.02979"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02979","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,19]]},"article-number":"2979"}}